Opendata, web and dolomites

Galastick

A medical device determining the daily amount of breast milk to improve neonatal nutrition andmothers’ psychophysics well-being.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Galastick project word cloud

Explore the words cloud of the Galastick project. It provides you a very rough idea of what is the project "Galastick" about.

biological    successfully    breastfeed    sme    reached    wellness    nutrition    omini    health    samples    frequent    trl    regulatory    player    amount    lack    occurs    feeding    improves    progressively    uses    prototype    daily    human    volunteer    preterm    absence    breastfeeding    newborn    flow    screened    chain    immunochromatographic    mother    hospitals    galascreen    breastmilk    donate    people    infants    confidence    milk    babies    colic    midwiferies    lactation    supervised    business    industrialize    pharma    preliminary    analyte    active    few    lateral    warning    onset    tested    plan    neonatal    works    proprietary    detecting    medical    psychological    integration    nervousness    feel    certified    reveals    stick    mothers    starts    assessing    assay    medically    device    diversity    150    company    market    depression    excess    simply    galastick    certifications    inadequate    engineer    donor    disposable    deep    commercialization    crying    strategy    undermining    reduce   

Project "Galastick" data sheet

The following table provides information about the project.

Coordinator
GALASCREEN SRLS 

Organization address
address: VIA SAVINIO ED. POLIFUNZIONALE DIPTO DI FARM
city: RENDE
postcode: 87036
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://talentlab.calabriainnova.it/galascreen/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.6. (SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GALASCREEN SRLS IT (RENDE) coordinator 50˙000.00
2    OMINI PHARMA SOCIETA A RESPONSABILITA LIMITATA SEMPLIFICATA IT (BUSSERO MILANO) participant 0.00

Map

 Project objective

'Biological diversity among people, reveals that not all mothers are the same. For some of them (not a few) it occurs that they are not able to successfully breastfeed their babies. Breastfeeding without 'feeding' can cause frequent crying and colic in the newborn and nervousness in mothers, lack of confidence in their abilities and depression. A mother starts to feel inadequate, undermining her psychological wellness. On the other hand, several mothers have breastmilk in excess and could donate it to preterm infants in midwiferies, thus promoting the babies' health and reduce hospitals' costs. Galascreen developed a proprietary disposable medical device, GalaStick, determining the lactation onset and the progressively increasing daily amount of breastmilk. The stick uses a lateral flow immunochromatographic assay that works simply detecting the presence (or absence) of a target analyte in the human milk sample. Such an easy to use stick not only improves the neonatal nutrition (warning if any feeding integration is needed), but also the psychological well-being of the mother. GalaStick has reached TRL 6 since a preliminary prototype has been tested with real human milk samples. More than 150 volunteer mothers and human milk donor mothers were successfully screened. Galascreen requires funding to engineer and industrialize the stick prototype and to get it medically certified as a medical device. Both key processes will be supervised and supported by the SME partner Omini Pharma. Phase 1 project will address a deep study on business development strategy and will define the value chain and the commercialization plan, together with assessing the regulatory procedures and certifications to be obtained by both the product and the company in order to be an active player on the medical market.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GALASTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GALASTICK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.6.;H2020-EU.2.3.1.)

KRTS (2015)

KRTS - The Art of Losing Weight

Read More  

Charity 24-7 (2017)

A social based online survey platform

Read More  

CAR-E (2017)

Creative Automotive Reuse E-commerce

Read More